Decoding the sweet regulation of apoptosis: the role of glycosylation and galectins in apoptotic signaling pathways (Q92564995)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30903104 AND SRC:MED&resulttype=core&format=json

30 April 2020

title

Decoding the sweet regulation of apoptosis: the role of glycosylation and galectins in apoptotic signaling pathways (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30903104 AND SRC:MED&resulttype=core&format=json

30 April 2020

1 reference

Kamil Seyrek

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30903104 AND SRC:MED&resulttype=core&format=json

30 April 2020

Max Richter

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30903104 AND SRC:MED&resulttype=core&format=json

30 April 2020

Inna N Lavrik

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30903104 AND SRC:MED&resulttype=core&format=json

30 April 2020

publication date

22 March 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30903104 AND SRC:MED&resulttype=core&format=json

Cell Death & Differentiation

30 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30903104 AND SRC:MED&resulttype=core&format=json

30 April 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30903104 AND SRC:MED&resulttype=core&format=json

30 April 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30903104 AND SRC:MED&resulttype=core&format=json

30 April 2020

page(s)

981-993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30903104 AND SRC:MED&resulttype=core&format=json

Apoptosis: a review of programmed cell death

30 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Death and anti-death: tumour resistance to apoptosis

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

The death domain superfamily: a tale of two interfaces?

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Death receptor signaling

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Life and death in peripheral T cells

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Differential modulation of apoptosis sensitivity in CD95 type I and type II cells.

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8.

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Cryo-EM Structure of Caspase-8 Tandem DED Filament Reveals Assembly and Regulation Mechanisms of the Death-Inducing Signaling Complex

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Co-operative and Hierarchical Binding of c-FLIP and Caspase-8: A Unified Model Defines How c-FLIP Isoforms Differentially Control Cell Fate

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Stoichiometry of the CD95 Death-Inducing Signaling Complex: Experimental and Modeling Evidence for a Death Effector Domain Chain Model

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Animal Lectins: Potential Antitumor Therapeutic Targets in Apoptosis

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Galectin-12 in Cellular Differentiation, Apoptosis and Polarization.

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

The Role of Galectins as Modulators of Metabolism and Inflammation.

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Galectin-3: The Impact on the Clinical Management of Patients with Thyroid Nodules and Future Perspectives

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Role of Galectins in Tumors and in Clinical Immunotherapy

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Galectin-7 in Epithelial Homeostasis and Carcinomas

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Oligosaccharide specificity of galectins: a search by frontal affinity chromatography.

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Galectin-3 in cardiac remodeling and heart failure

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Galectins: structure, function and therapeutic potential

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Galectins as Molecular Targets for Therapeutic Intervention.

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Crystal structure of the galectin-9 N-terminal carbohydrate recognition domain from Mus musculus reveals the basic mechanism of carbohydrate recognition.

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

The role of galectin-3 in cancer drug resistance

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Intracellular functions of galectins

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

On the role of galectin-3 in cancer apoptosis

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Multivalent protein-carbohydrate interactions. A new paradigm for supermolecular assembly and signal transduction

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Spatiotemporal organization of Ras signaling: rasosomes and the galectin switch

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Expression of galectin-3 modulates T-cell growth and apoptosis

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Role of Galectins in Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Clusters, bundles, arrays and lattices: novel mechanisms for lectin-saccharide-mediated cellular interactions

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

The galectin lattice at a glance

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Functions of cell surface galectin-glycoprotein lattices

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Understanding apoptosis by systems biology approaches

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b.

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

The active caspase-8 heterotetramer is formed at the CD95 DISC

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c.

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Differential sialylation of cell surface glycoconjugates in a human B lymphoma cell line regulates susceptibility for CD95 (APO-1/Fas)-mediated apoptosis and for infection by a lymphotropic virus

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Modulation of the CD95-Induced Apoptosis: The Role of CD95 N-Glycosylation

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Sialylation of the Fas Death Receptor by ST6Gal-I Provides Protection against Fas-mediated Apoptosis in Colon Carcinoma Cells

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Glycobiology of cell death: when glycans and lectins govern cell fate

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

SHIP-1 inhibits CD95/APO-1/Fas-induced apoptosis in primary T lymphocytes and T leukemic cells by promoting CD95 glycosylation independently of its phosphatase activity

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Palmitoylation of CD95 facilitates formation of SDS-stable receptor aggregates that initiate apoptosis signaling

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Requirement of N-glycosylation for the secretion of recombinant extracellular domain of human Fas in HeLa cells

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

N-glycosylation of mouse TRAIL-R and human TRAIL-R1 enhances TRAIL-induced death

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL.

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

N-glycosylation of mouse TRAIL-R restrains TRAIL-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Fas/CD95-induced chemokines can serve as "find-me" signals for apoptotic cells

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Transient silencing of galectin-3 expression promotes both in vitro and in vivo drug-induced apoptosis of human pancreatic carcinoma cells

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Galectin-3 and Cancer Stemness.

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Endogenous galectin-3 determines the routing of CD95 apoptotic signaling pathways.

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Galectin-1 induced activation of the apoptotic death-receptor pathway in human Jurkat T lymphocytes

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Galectin-1 Sensitizes Resting Human T Lymphocytes to Fas (CD95)-mediated Cell Death via Mitochondrial Hyperpolarization, Budding, and Fission

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

The role of T-cell immunoglobulin mucin-3 and its ligand galectin-9 in antitumor immunity and cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Cancer Therapy Due to Apoptosis: Galectin-9.

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Targeting activating transcription factor 3 by Galectin-9 induces apoptosis and overcomes various types of treatment resistance in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

A modified version of galectin-9 suppresses cell growth and induces apoptosis of human T-cell leukemia virus type I-infected T-cell lines

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Therapeutic potential of Galectin-9 in human disease

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Targeted induction of apoptosis for cancer therapy: current progress and prospects.

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Turning cell cycle controller genes into cancer drugs. A role for an antiproliferative cytokine (betaGBP).

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Galectin-1 induces nuclear translocation of endonuclease G in caspase- and cytochrome c-independent T cell death

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Biphasic modulation of cell growth by recombinant human galectin-1.

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Galectin-1 is a novel structural component and a major regulator of h-ras nanoclusters

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Concepts and advances in cancer therapeutic vulnerabilities in RAS membrane targeting

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Human galectin-2: novel inducer of T cell apoptosis with distinct profile of caspase activation

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Galectin-3 regulates T-cell functions

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Galectin-3 mediates the endocytosis of beta-1 integrins by breast carcinoma cells

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Galectin-glycan lattices regulate cell-surface glycoprotein organization and signalling

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Structure-function analysis of Bcl-2 protein. Identification of conserved domains important for homodimerization with Bcl-2 and heterodimerization with Bax.

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Why anti-Bcl-2 clinical trials fail: a solution

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Galectin-3 inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by activating Akt in human bladder carcinoma cells.

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Repression of the antiapoptotic molecule galectin-3 by homeodomain-interacting protein kinase 2-activated p53 is required for p53-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs.

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria. A role for synexin in galectin-3 translocation

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Mitochondrial proteomic approach reveals galectin-7 as a novel BCL-2 binding protein in human cells

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Galectin-7 (PIG1) exhibits pro-apoptotic function through JNK activation and mitochondrial cytochrome c release

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

The involvement of CD44 and its novel ligand galectin-8 in apoptotic regulation of autoimmune inflammation

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Galectin-8 induces apoptosis in Jurkat T cells by phosphatidic acid-mediated ERK1/2 activation supported by protein kinase A down-regulation

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin.

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Galectin-12, an Adipose-expressed Galectin-like Molecule Possessing Apoptosis-inducing Activity

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Expression profiling of cancer-related galectins in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Synthesis of O-galactosyl aldoximes as potent LacNAc-mimetic galectin-3 inhibitors

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

3-(1,2,3-Triazol-1-yl)-1-thio-galactosides as small, efficient, and hydrolytically stable inhibitors of galectin-3.

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Synthesis of a phenyl thio-beta-D-galactopyranoside library from 1,5-difluoro-2,4-dinitrobenzene: discovery of efficient and selective monosaccharide inhibitors of galectin-7.

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Pharmacokinetics and antineoplastic activity of galectin-1-targeting OTX008 in combination with sunitinib.

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Galectins and Carcinogenesis: Their Role in Head and Neck Carcinomas and Thyroid Carcinomas

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

Inhibition of Galectin-1 Sensitizes HRAS-driven Tumor Growth to Rapamycin Treatment

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death

1 reference

https://api.crossref.org/works/10.1038/S41418-019-0317-6

7 January 2021

10.1038/S41418-019-0317-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30903104 AND SRC:MED&resulttype=core&format=json

30 April 2020

1 reference